Soleil Securities Initiates Coverage on Omnicare (OCR) with a Hold
More News related to OCR
- Omnicare Declares Quarterly Cash Dividend
- Omnicare Announces Resignation of Jeffrey W. Ubben from Board of Directors
- Omnicare to Host Analyst/Investor Day
- Omnicare to Present at the Credit Suisse Healthcare Conference
- Morgan Stanley Upgrades Omnicare (OCR) to Equalweight
More News related to New Coverage
- Friedman Billings Starts Aircastle (AYR) at Underperform
- Friedman Billings Starts Netflix (NFLX) at Market Perform
- Credit Suisse Starts 3PAR (PAR) at Neutral
- Credit Suisse Starts Netezza (NZ) at Neutral
- FBR Starts Amazon.com (AMZN) at Market Perform
Soleil Securities initiates coverage on Omnicare, Inc. (NYSE: OCR) with a Hold. Price target $34.50.
Soleil analyst says, "In our opinion, limited near term upside potential with stock rebound after management increased guidance following 2QR. Despite an on-going major initiative to enhance operating efficiency and increase customer growth, significant issues remain."
Omnicare, Inc. (Omnicare) is a geriatric pharmaceutical services company. The Company operates in two segments: Pharmacy Services and Contract Research Organization Services (CRO Services).
Related Categories
New CoverageStocks Mentioned
-2.10Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
